Shares in Corindus Vascular Robotics (NYSE:CVRS) fell today after the medical posted 1st quarter earnings that missed expectations on Wall Street. The Waltham, Mass.-based company posted losses of $9.9 million, or 7¢, on sales of $777,000 for the 3 months ended March 31, seeing losses grow 29.6% while sales shrunk 29.9% compared with the same period […]
Corindus Vascular Robotics
Corindus registers for $60m mixed shelf offering
Corindus Vascular Robotics (NYSE:CVRS) this week registered for an upcoming mixed shelf offering worth up to $60 million. The company said that net proceeds from the round are currently slated to support further commercialization of its coronary robotic-assisted intervention programs as well as expanding the capabilities of its CorPath system, according to an SEC filing. The […]
7 medtech stories we missed this week: March 31, 2017
This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia. Here are 7 medtech stories we missed this week but thought were still worth mentioning: 1. Corindus touts first Asian use of next-generation robot Corindus Vascular Robotics announced in a March 31 press […]
Corindus closes $45m offering, sees shares slide on Q4, FY2016 earnings miss
Corindus Vascular Robotics (NYSE:CVRS) this week announced the closing of a $45 million offering and 4th quarter and fiscal year 2016 earnings which just missed expectations on Wall Street. In the offering, Waltham, Mass.-based Corindus floated an aggregate of 68.1 million shares of common stock at 66¢ per share, with proceeds intended to support general corporate […]
Corindus inks robotic R&D, training partnership deal with WakeMed
Corindus Vascular Robotics (NYSE:CVRS) said today it inked a partnership deal with WakeMed Health & Hospitals. Through the deal, the groups will develop a center which aims to advance clinical robotics research and train interventional cardiologists on robotic-assisted percutaneous coronary interventions using its CorPath GRX system, the Waltham, Mass.-based company said. “Our top priority is to provide […]
Boston Scientific gets in on $45m private placement for Corindus Vascular Robotics
Boston Scientific (NYSE:BSX) got in on a $45 million private placement for Corindus Vascular Robotics (NYSE:CVRS) and the CorPath GRX device it’s developing for cardiac and peripheral vascular procedures. New investors BioStar Ventures, Consonance Capital and Hudson Executive Capital also participated, joining existing backers HealthCor Partners Management and Royal Philips (NYSE:PHG). “We are pleased to announce this financing and appreciate […]
Corindus inks Japanese distribution deal for CorPath GRX
Corindus Vascular Robotics (OTC:CVRS) said today that it inked a Japanese distribution deal for its CorPath GRX device that includes a $2 million advance and provision for 12 of the robot-assisted surgery platforms. The deal with MC Healthcare subsidiary Japan Medicalnext calls for an initial order of a dozen systems within 30 days with a $2 million advance toward the […]
Corindus touts 1st commercial use of 2nd-gen CorPath robotic platform
Corindus Vascular Robotics (OTC:CVRS) said today that its CorPath GRX 2nd-generation vascular robot-assisted surgery platform was used in its 1st commercial procedures. The robotic platform was used early this month at the NewYork-Presbyterian hospital, UC San Diego Health and University of Virginia Health System in robotic-assisted PCI procedures, the company said. It began early installations of […]
11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest surgical robot players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find […]
Corindus jumps on raised outlook
Shares in Corindus Vascular Robotics (OTC:CVRS) jumped nearly 11% in morning trading today after the company raised its outlook for full-year revenue in 2017 to between $13 million – $15 million. Analysts have pegged the robotic-assisted systems maker’s full-year revenue for 2017 at $12 million. Corindus said in a report yesterday that it anticipates implementation of at least […]
Corindus wins FDA nod for 2nd-gen CorPath GRX vascular robot-assisted surgery system
Corindus Vascular Robotics (OTC:CVRS) said yesterday that it won 510(k) clearance from the FDA for the CorPath GRX, it’s 2nd-generation vascular robot-assisted surgery platform, and plans to have it on the market during the 1st quarter of 2017. Waltham, Mass.-based Corindus said it added several features to the latest CorPath iteration, including the ability to control the guide catheter […]